Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 243, Issue 1, 2005, Pages 9-12

  Augustin, Albert J ^a   D'Amico, Donald J ^a   Mieler, William F ^a   Schneebaum, Cary ^a   Beasley, Cliff ^a  

^a STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANECORTAVE; ANESTHETIC AGENT; FLUORESCEIN; INDOCYANINE GREEN; PLACEBO;

ARTICLE; BLOOD CHEMISTRY; CANNULA; CATARACT; CLINICAL TRIAL; CONJUNCTIVAL HEMORRHAGE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; EUROPEAN UNION; EYE PAIN; FLUORESCENCE ANGIOGRAPHY; FREQUENCY ANALYSIS; HEALTH CARE ORGANIZATION; HEMATOLOGY; HUMAN; INTRAOCULAR FOREIGN BODY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PTOSIS; RANDOMIZED CONTROLLED TRIAL; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; SCLERA; SUBRETINAL NEOVASCULARIZATION; SUSPENSION; UNITED STATES; URINALYSIS; VISUAL ACUITY; VISUAL DISORDER; VISUAL SYSTEM EXAMINATION;

ANGIOGENESIS INHIBITORS; CHOROIDAL NEOVASCULARIZATION; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; INTRAOCULAR PRESSURE; MACULAR DEGENERATION; PREGNADIENEDIOLS; SAFETY; SCLERA; VISUAL ACUITY;

EID: 12444259836     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-004-0961-4     Document Type: Article

References (10)

1. Anecortave Acetate Clinical Study Group (2003) Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): Interim (month 6) analysis of clinical safety and efficacy. Retina 23:14-23 12652226
2. Anecortave Acetate Clinical Study Group (2003) Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: The twelve-month clinical outcomes. Ophthalmology 110:2372-2383 10.1016/j.ophtha.2003.08.020
3. BenEzra D, Griffin BW, Maftzir G, Sharif NA, Clark AF (1997) Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest Ophthalmol Vis Sci 38:1954-1962 1:STN:280:ByiH2s%2FnvF0%3D
4. Clark AF (1997) AL-3789: A novel ophthalmic angiostatic steroid. Expert Opin Investig Drugs 6:1867-1877 1:CAS:528:DyaK2sXnvFGnt74%3D
5. Clark AF, Mellon J, Li X-Y, Ma D, Lieber H, Apte R, Alizadeh H, Hegde S, McLenaghan A, Mayhew E, D'Orazio TJ, Niederkorn JY (1999) Inhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetate. Invest Ophthalmol Vis Sci 40:2158-2162 1:STN:280:DyaK1Mzms1yrtA%3D%3D
6. Cochereau-Massin I, Lehoang P, Lautier-Frau M, Zazoun L, Marcel P, Robinet M, Matheron S, Katlama C, Gharakhanian S, Rozenbaum W, Ingrand D, Gentilini M (1991) Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 98:1348-1355 1:STN:280:By2D2M%2FmvVQ%3D
7. Heinemann M-H (1989) Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy. Arch Ophthalmol 107:1767-1772 1:STN:280:By%2BD1cfislM%3D
8. McNatt LG, Weimer L, Yanni J, Clark AF (1999) Angiostatic activity of steroids in the chick embryo CAM and rabbit corneal pocket models of neovascularization. J Ocul Pharmacol 15:413-423 1:CAS:528:DyaK1MXmslagsbc%3D
9. Nelson ML, Tennant MTS, Sivalingam A, Regillo CD, Belmont J, Martidis A (2003) Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 23:686-691 10.1097/00006982-200310000-00014
10. Penn JS, Rajaratnam VS, Collier RJ, Clark AF (2001) The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 42:283-290 1:STN:280:DC%2BD3M%2Fosl2hsg%3D%3D